🇺🇸 FDA
Patent

US 10913957

Genetically modified MSC and therapeutic methods

granted A61KA61K48/005

Quick answer

US patent 10913957 (Genetically modified MSC and therapeutic methods) held by The Regents of the University of California expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K48/005